Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
2008 | Acute Q fever presenting as fever of unknown origin with rapidly progressive hepatic failure in a patient with alcoholism | PO-HAN LIN ; Lo, Yi Chun; FU-TIEN CHIANG ; Wang, Jiun Ling; YUNG-MING JENG ; CHI-TAI FANG ; SHAN-CHWEN CHANG | Journal of the Formosan Medical Association | 6 | 5 | |
2021 | Circulating Tumor DNA as a Predictive Marker of Recurrence for Patients With Stage II-III Breast Cancer Treated With Neoadjuvant Therapy | PO-HAN LIN ; MING-YANG WANG ; Lo, Chiao; LI-WEI TSAI ; Yen, Tzu-Chun; Huang, Thomas Yoyan; Huang, Wei-Chih; Yang, Karen; Chen, Chih-Kai; Fan, Sheng-Chih; SUNG-HSIN KUO ; CHIUN-SHENG HUANG | Frontiers in Oncology | 6 | 4 | |
2011 | Cisplatin as an active treatment in zoledronate-refractory hypercalcemia | PO-HAN LIN ; Chiu C.-F.; YEN-SHEN LU | Annals of Oncology | 1 | 1 | |
2013 | Clinical and pathologic risk factors of tumor recurrence in patients with node-negative early breast cancer after mastectomy | PO-HAN LIN ; Yeh M.-H.; Liu L.-C.; Chen C.-J.; Tsui Y.-C.; Su C.-H.; Wang H.-C.; Liang J.-A.; Chang H.-W.; Wu H.-S.; Yeh S.-P.; Li L.-Y.; Chiu C.-F. | Journal of Surgical Oncology | 13 | 12 | |
2017 | Combination of palbociclib with enzalutamide shows in vitro activity in RB proficient and androgen receptor positive triple negative breast cancer cells | Liu C.-Y.; Lau K.-Y.; Hsu C.-C.; Chen J.-L.; Lee C.-H.; Huang T.-T.; Chen Y.-T.; Huang C.-T.; PO-HAN LIN ; Tseng L.-M. | PLoS ONE | 39 | 35 | |
2021 | A DNA Damage Response Gene Panel for Different Histologic Types of Epithelial Ovarian Carcinomas and Their Outcomes | YING-CHENG CHIANG ; PO-HAN LIN ; TZU-PIN LU ; KUAN-TING KUO ; YI-JOU TAI ; HENG-CHENG HSU ; CHIA-YING WU ; Lee, Chia-Yi; Shen, Hung; CHI-AN CHEN ; WEN-FANG CHENG | Biomedicines | 2 | 2 | |
2012 | Evaluation of breast cancer susceptibility loci on 2q35, 3p24, 17q23 and FGFR2 genes in Taiwanese women with breast cancer | Lin C.-Y.; Ho C.-M.; Bau D.-T.; Yang S.-F.; Liu S.-H.; PO-HAN LIN ; Lin T.-H.; Tien N.; Shih M.-C.; Lu J.-J. | Anticancer Research | 12 | 13 | |
2016 | Genes involved in angiogenesis and mTOR pathways are frequently mutated in Asian patients with pancreatic neuroendocrine tumors | Chou, Wen-Chi; PO-HAN LIN ; Yeh, Yi-Chen; Shyr, Yi-Ming; Fang, Wen-Liang; Wang, Shin-E.; Liu, Chun-Yu; Chang, Peter Mu-Hsin; Chen, Ming-Han; Hung, Yi-Ping; Li, Chung-Pin; Chao, Yee; YI-PING HUNG | International Journal of Biological Sciences | 28 | 26 | |
2021 | Homologous Recombination Deficiency Assays in Epithelial Ovarian Cancer: Current Status and Future Direction | YING-CHENG CHIANG ; PO-HAN LIN ; WEN-FANG CHENG | Frontiers in Oncology | 12 | 11 | |
2022 | Impact of BRCA mutation on the survival and risk of contralateral breast cancer in Asian breast cancer patients | PO-HAN LIN ; Chen, Shin-Cheh; Tseng, Ling-Ming; Chang, King-Jen; Huang, Ai-Chu; Cheng, Kuo-Chih; Yang, Karen; Wu, Hui-Chen; Chao, Tsu-Yi; Chang, Yuan-Ching; Lin, Peng-Chan; WEN-HUNG KUO ; Kuo, Wen-Lin; CHING-HUNG LIN ; Chen, Huo-Mu; Yeh, Dah-Cherng; Liu, Liang-Chih; Liu, Chun-Yu; MING-YANG WANG ; Lo, Chiao; YEN-SHEN LU ; CHIUN-SHENG HUANG | Breast cancer research and treatment | 0 | 0 | |
2012 | Multimodel assessment of BRCA1 mutations in Taiwanese (ethnic Chinese) women with early-onset, bilateral or familial breast cancer | WEN-HUNG KUO ; PO-HAN LIN ; Huang A.-C.; YIN-HSIU CHIEN ; Liu T.-P.; YEN-SHEN LU ; Bai L.-Y.; Sargeant A.M.; CHING-HUNG LIN ; ANN-LII CHENG ; Hsieh F.-J.; WUH-LIANG HWU ; KING-JEN CHANG | Journal of Human Genetics | 18 | 18 | |
2016 | Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer | PO-HAN LIN ; WEN-HUNG KUO ; Huang A.-C.; YEN-SHEN LU ; CHING-HUNG LIN ; SUNG-HSIN KUO ; Wang M.-Y.; Liu C.-Y.; Cheng F.T.-F.; Yeh M.-H.; Li H.-Y.; Yang Y.-H.; Hsu Y.-H.; Fan S.-C.; Li L.-Y.; SUNG-LIANG YU ; KING-JEN CHANG ; PEI-LUNG CHEN ; YEN-HSUAN NI ; CHIUN-SHENG HUANG | Oncotarget | 69 | 61 | |
2022 | Neoadjuvant afatinib with paclitaxel for triple-negative breast cancer and the molecular characteristics in responders and non-responders | PO-HAN LIN ; Tseng L.-M.; Lee Y.-H.; Chen S.-T.; Yeh D.-C.; Dai M.-S.; Liu L.-C.; MING-YANG WANG ; Lo C.; Chang S.; Tan K.T.; Chen S.-J.; SUNG-HSIN KUO ; Huang C.-S. | Journal of the Formosan Medical Association | 1 | 1 | |
2012 | Novel heterozygous tissue-nonspecific alkaline phosphatase (TNAP) gene mutations causing lethal perinatal hypophosphatasia | KAI-CHI CHANG ; PO-HAN LIN ; Su Y.-N.; STEVEN SHINN-FORNG PENG ; NI-CHUNG LEE ; HUNG-CHIEH CHOU ; CHIEN-YI CHEN ; Hsieh W.-S.; PO-NIEN TSAO | Journal of Bone and Mineral Metabolism | 14 | 12 | |
2013 | OSU-A9, an indole-3-carbinol derivative, induces cytotoxicity in acute myeloid leukemia through reactive oxygen species-mediated apoptosis | Bai L.-Y.; Weng J.-R.; Chiu C.-F.; Wu C.-Y.; Yeh S.-P.; Sargeant A.M.; PO-HAN LIN ; Liao Y.-M. | Biochemical Pharmacology | 27 | 27 | |
2003 | Oxidative damage to mitochondrial DNA in atrial muscle of patients with atrial fibrillation | PO-HAN LIN ; Lee, Shih Huang; Su, Chia Ping; Wei, Yau Huei | Free Radical Biology & Medicine | 104 | 99 | |
2014 | Palonosetron and dexamethasone for the prevention of nausea and vomiting in patients receiving allogeneic hematopoietic stem cell transplantation | Yeh S.-P.; Lo W.-C.; Hsieh C.-Y.; Bai L.-Y.; Lin C.-C.; PO-HAN LIN ; Lin C.-Y.; Liao Y.-M.; Chiu C.-F. | Supportive Care in Cancer | 8 | 2 | |
2017 | Polymorphisms of ESR1, UGT1A1, HCN1, MAP3K1 and CYP2B6 are associated with the prognosis of hormone receptor-positive early breast cancer | SUNG-HSIN KUO ; Yang S.-Y.; You S.-L.; HUANG-CHUN LIEN ; CHING-HUNG LIN ; PO-HAN LIN ; CHIUN-SHENG HUANG | Oncotarget | 31 | 27 | |
2013 | Prognostic analysis of adjuvant chemotherapy in patients with nasopharyngeal carcinoma | Lin C.-C.; Chen T.-T.; Lin C.-Y.; Hsieh C.-Y.; PO-HAN LIN ; Chien C.-R.; Chiu C.-F.; Yeh S.-P. | Future Oncology | 6 | 5 | |
2013 | Prognostic impact of allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia patients with internal tandem duplication of FLT3 | PO-HAN LIN ; Lin C.-C.; Yang H.-I.; Li L.-Y.; Bai L.-Y.; Chiu C.-F.; Liao Y.-M.; Lin C.-Y.; Hsieh C.-Y.; Lin C.-Y.; Ho C.-M.; Yang S.-F.; Peng C.-T.; Tsai F.-J.; Yeh S.-P. | Leukemia Research | 34 | 31 | |